DE60233601D1 - Use of certain cyclolignans - Google Patents

Use of certain cyclolignans

Info

Publication number
DE60233601D1
DE60233601D1 DE60233601T DE60233601T DE60233601D1 DE 60233601 D1 DE60233601 D1 DE 60233601D1 DE 60233601 T DE60233601 T DE 60233601T DE 60233601 T DE60233601 T DE 60233601T DE 60233601 D1 DE60233601 D1 DE 60233601D1
Authority
DE
Germany
Prior art keywords
cyclolignans
certain
certain cyclolignans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233601T
Other languages
German (de)
Inventor
Olle Larsson
Magnus Axelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axelar AB
Original Assignee
Axelar AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0102168A external-priority patent/SE0102168D0/en
Application filed by Axelar AB filed Critical Axelar AB
Application granted granted Critical
Publication of DE60233601D1 publication Critical patent/DE60233601D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60233601T 2001-06-19 2002-06-19 Use of certain cyclolignans Expired - Lifetime DE60233601D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102168A SE0102168D0 (en) 2001-06-19 2001-06-19 New use and new compounds
US30043101P 2001-06-26 2001-06-26

Publications (1)

Publication Number Publication Date
DE60233601D1 true DE60233601D1 (en) 2009-10-15

Family

ID=26655492

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233601T Expired - Lifetime DE60233601D1 (en) 2001-06-19 2002-06-19 Use of certain cyclolignans

Country Status (5)

Country Link
JP (1) JP2009242406A (en)
KR (1) KR20040030686A (en)
AU (2) AU2009201542B2 (en)
DE (1) DE60233601D1 (en)
NO (1) NO20035647L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100971364B1 (en) * 2009-12-28 2010-07-20 명 하 윤 Adapter for oil pressure division of excavator glove cylinder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004062A1 (en) * 1984-12-28 1986-07-17 Conpharm Ab Pharmaceutically active compound and a method for its preparation
JPH09194368A (en) * 1996-01-11 1997-07-29 Pola Chem Ind Inc Podophyllotoxin derivative and new cell differentiation inducer comprising the same

Also Published As

Publication number Publication date
AU2010200488A1 (en) 2010-03-04
NO20035647D0 (en) 2003-12-17
NO20035647L (en) 2004-02-18
JP2009242406A (en) 2009-10-22
KR20040030686A (en) 2004-04-09
AU2009201542B2 (en) 2011-06-23
AU2009201542A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
DE50212455D1 (en) Use of dimerdiols
ATE370938T1 (en) PRO-PHARMACON OF COX-2 INHIBITORS
DE60236226D1 (en) Improvement of presbyopia
DE60217432D1 (en) Uses of carbon fibers
DK1360169T3 (en) Succinate salt of O-desmethyl-venlafaxine
DE60211601D1 (en) Provision of positional content
ATE510556T1 (en) USE OF ERYTHROPOIETIN
DE02784674T1 (en) QUANTIFICATION OF POLYPEPTIDES
DE60204093D1 (en) Substance mixture of triphenylamine dimers
DE502004011575D1 (en) Use of Dioldimerfettsäureestern
ITMI20021038A0 (en) ARRANGEMENT OF ELECTRODES
NO20041968L (en) Use of cystationin
ATE275390T1 (en) USE OF CATIONIC PREPARATIONS
DE60227828D1 (en) E OF MELT ADHESIVE
DE60318819D1 (en) HITZESTABILE MUTANTS OF STRENGTH BIOSYNTHESEENZYMEN
DE50311406D1 (en) Use of moldings
ATE556564T1 (en) ALLOCATION OF TIME SLOTS
DE60226710D1 (en) COMBINATION OF DOCETAXEL WITH FLAVOPIRIDOL
DE60007360T2 (en) AMORPHE MODIFICATION OF TORASEMID
DE50103099D1 (en) Use of cationic preparations
DE60330315D1 (en) ACYLFLUORIDE ACTIVATION OF CARBOXYSILYL-COATED GLASSES
DE60233601D1 (en) Use of certain cyclolignans
DE50205590D1 (en) REPLACEMENT OF HEADS
DE50203046D1 (en) Use of esterquats
ATE348606T1 (en) NEW USE OF PIPATALIN

Legal Events

Date Code Title Description
8364 No opposition during term of opposition